cached image

Avi Friedlich, MD, Case Western Reserve University

Affiliations: 
Psychiatry Harvard University, Cambridge, MA, United States 
Area:
Alzheimer disease
Website:
http://manicdepressive.org/staff.php?staff_group=Previous%20Staff
Google:
"Avi Friedlich"
Bio:

http://www.vitals.com/doctors/Dr_Avi_Friedlich.html

http://www.linkedin.com/in/friedlich
http://www.harvardsouthshorepsychiatry.org/Alumni

http://web.mit.edu/~bcs/people/researchers.shtml

Cross-listing: Neurotree - Alzheimer's Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bonda DJ, Lee HP, Lee HG, et al. (2010) Novel therapeutics for Alzheimer's disease: an update. Current Opinion in Drug Discovery & Development. 13: 235-46
Friedlich AL, Rolston RK, Zhu X, et al. (2009) Treatment advances in Alzheimer's disease based on the oxidative stress model. F1000 Medicine Reports. 1
Yi J, Horky LL, Friedlich AL, et al. (2009) L-arginine and Alzheimer's disease. International Journal of Clinical and Experimental Pathology. 2: 211-38
Friedlich AL, Smith MA, Zhu X, et al. (2009) Oxidative Stress in Parkinson`s Disease The Open Pathology Journal. 3: 38-42
Puglielli L, Friedlich AL, Setchell KD, et al. (2005) Alzheimer disease beta-amyloid activity mimics cholesterol oxidase. The Journal of Clinical Investigation. 115: 2556-63
Friedlich AL, Bush AI. (2005) Copper and zinc in Alzheimer's disease and amyotrophic lateral sclerosis Neurodegenerative Diseases: Neurobiology, Pathogenesis and Therapeutics. 157-165
Friedlich AL, Lee JY, van Groen T, et al. (2004) Neuronal zinc exchange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 3453-9
Andreassen OA, Dedeoglu A, Ferrante RJ, et al. (2001) Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease. Neurobiology of Disease. 8: 479-91
Andreassen OA, Dedeoglu A, Friedlich A, et al. (2001) Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice. Experimental Neurology. 168: 419-24
Friedlich AL, Beal MF. (2000) Prospects for redox-based therapy in neurodegenerative diseases. Neurotoxicity Research. 2: 229-37
See more...